The synthetic biology market was valued at USD 22.47 billion, in 2018. The market is expected to register a growth rate of 34.91% over the forecast period. The primary drivers for the market include increasing support from government and private institutions and increasing R&D investments in drug discovery and development. Based on the product, the market was dominated by the enabled product in 2018. The fastest growing subsegment over the forecast period, under the product segmentation, was estimated to be enabled products. The enabled product sub-segment is expected to register a CAGR of 35.19% over the forecast period.

The adoption of single-use technology has proven to be a robust, scalable, and reliable form of sources from lab-scale to cGMP production applications, such as flexible contaminant, single-use bioprocessing equipment, and single-use filtration assemblies. Hence, the use of single-use technologies in virus filtration helps to marginally reduce the risk of cross-contamination, increasing the safety profile of the manufacturing process.

Currently, the healthcare industry in Nigeria is hindered by the lack of funds from the Nigerian government, often resulting in insufficient supply of medical equipment, administrative bottlenecks, and limited licensed medical laboratory professionals. The public healthcare expenditures are really less accounting for only about 5%, and private (out of pocket) expenditure to about 75%. This statistic is drastically different from several developed and emerging markets.

The integration of robotics and automation in labs is rapidly increasing, owing to the enhanced productivity and mitigated operational cost for laboratories. This is likely to boost the market growth during the forecast period. The progress in research and discovery of the organs, including the polymerase chain reaction (PCR), splice genes, means of sequencing, are on a rise, which may propel the market growth.

The general view on biostimulants is that they are neither fertilizers nor pesticides, and are in some ways beneficial to the plant body. Given the urgent need to enhance the productivity of agricultural lands, this niche segment has been registering robust growth. Regional bodies, such as the European Biostimulant Industry Council (EBIC) and Biostimulant Coalition, have defined the segment to provide a clear picture.

The increasing environmental awareness and growing threats to the ecology have been forcing government bodies and regulatory agencies around the world to develop newer practices, in order to create sustainable human communities. As a part of the same, there have been many developments lately to enhance the recyclability of resources, such as wastewater sludge and excreta (the primary sources of biosolids), as they are dangerous to both the human health and the environment, if not managed properly. The pollution prevention programs and industrial pretreatment in the United States have substantially reduced levels of metals and other pollutants going into wastewater treatment plants, resulting in noticeable improvements in biosolids’ quality. The capital expenditure and management of municipal wastewater treatment services has been increasing in the recent times in the United States. The Public Owned Treatment Works (POTW) in the United States produces nearly 0.16 pounds (by dry weight) of sewage sludge per person per day, among the total sewage treatment services.

我们认为云游戏与AR/VR 等新一代智能硬件结合，可能成为5G 时代的第一个杀手级应用。5G 解决了困扰云游戏及AR/VR 很多年的网络带宽和延迟问题，3D 视觉、语音交互等AI 功能也为游戏带来更好的体验。我们看到中国移动、中国联通等电信运营商，亚马逊、微软、谷歌、腾讯、阿里巴巴等互联网公司，索尼、英伟达等硬件企业都在积极布局与探索云游戏的商业模式，云游戏与AR/VR 硬件亦会相辅相成。建议投资人关注AR/VR 近眼显示光学方案、AR/VR 芯片平台、追踪相机与传感器等产业链核心环节。

至2019 年7 月15 日，A 股创业板所有767 家公司已全部披露中期预告。根据公布的数据测算，创业板中期预告净利润共计569 亿元，同比增速-1.0%，相比一季度有所改善，剔除温氏后，同比增速-1.84%，相对一季度剔除温氏的数据也有所改善；二季度单季度净利润共计324 亿元，环比增长32.7%。相比19 年一季度有所改善，上市公司并购重组的商誉减值已在2018 年年底渡过高峰期，带来一季报和中报预告中创业板整体净利润水平的恢复，体现在了环比增长的数据中。

创业板披露率约为95%，中小板披露率约50%。整体法下，创业板2019H1盈利增速为2.3%，Q2 单季度为12.7%，中小板2019H1 盈利增速为5.5%，Q2 单季度为22.6%。科技行业（计算机、通信、电子、传媒、军工和电力设备）2019 年上半年净利润增速（整体法）为-0.6%，Q2 单季度净利润增速为10%。计算机、通信、电子、电力设备、机械行业Q2 单季度盈利增速均超过15%。